31.7 C
New York
Sunday, June 14, 2026

Tag: derivatives

Progress on share buyback programme

Progress on share buyback programme

 HighPeak Energy, Inc. Announces Second Quarter 2025 Financial and Operating Results

FORT WORTH, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter ended June 30, 2025.

MicroCloud Hologram Inc. Announces Significant Returns from Crypto Asset Strategic Investment: Cumulative Investment Returns Reach $40.45 Million

SHENZHEN, China, Aug. 11, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, announced that the company's...

Intas & Accord signs Agreement to acquire Prothya Biosolutions

AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of an agreement to acquire...

Intas & Accord signs Agreement to acquire Prothya Biosolutions

AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of an agreement to acquire...

Double Deposit Bonus, $50 Welcome Bonus & No-KYC 100x Leverage Trading Now Available on BexBack

SINGAPORE, Aug. 09, 2025 (GLOBE NEWSWIRE) -- With Bitcoin surpassing the $110,000 mark and stabilizing above that level, many analysts predict the cryptocurrency market will remain in a high-volatility phase for the foreseeable future. Holding spot positions may no longer yield quick profits in such a market. In response, BexBack Exchange is offering traders an unbeatable package to take advantage of these market conditions. The platform now features a 100% deposit bonus, a $50 welcome bonus for new users, and 100x leverage on cryptocurrency trading, giving investors incredible opportunities to maximize returns.

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its second quarter 2025 operating and financial results and reviewed recent business highlights.

Standard Lithium Reports Second Quarter 2025 Results

VANCOUVER, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three month period ended June 30, 2025.

Plains All American Reports Second-Quarter 2025 Results

HOUSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported solid second-quarter 2025 results and provided the following highlights:

Calumet Reports Second Quarter 2025 Results

Second quarter 2025 net loss of $147.9 million, or basic loss per common share of $1.70 per shareSecond quarter 2025 Adjusted EBITDA with Tax...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDerivatives